Persistent Opioid Use High in Head, Neck Cancer Patients

Share this content:
Persistent Opioid Use High in Head, Neck Cancer Patients
Persistent Opioid Use High in Head, Neck Cancer Patients

FRIDAY, Jan. 11, 2019 (HealthDay News) -- Persistent opioid use at three and six months remains high among patients undergoing treatment for head and neck squamous cell cancer, according to a study recently published in Otolaryngology-Head and Neck Surgery.

Jessica D. McDermott, M.D., from the University of Colorado Anschutz School of Medicine in Aurora, and colleagues used data from the Surveillance, Epidemiology and End Results-Medicare database (2008 to 2011) to identify 976 nondistant metastatic oral cavity and oropharynx patients undergoing treatment.

The researchers found that 83.1 percent of patients received an opioid prescription during the treatment period, while 15.4 and 7.0 percent of patients had continued opioid prescriptions at three and six months, respectively. There was an association between prescriptions prior to treatment and opioid use during treatment (odds ratio, 3.28). Tobacco use (odds ratios, 2.23 and 3.84) and opioids prescribed prior to treatment (odds ratios, 3.84 and 3.56) were risk factors associated with continued opioid use at three and six months, respectively. Ongoing use at three and six months was least likely if oxycodone was prescribed as the first opioid (odds ratios, 0.33 and 0.26, respectively).

"If a patient needed opioids for pain, I wouldn't keep them away, but especially if they have risk factors, I might counsel them more about the risks of addiction and misuse, and keep an eye on it," McDermott said in a statement.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: Progress in HIV Prevention Has Stalled in the United States

CDC: Progress in HIV Prevention Has Stalled in ...

Agency says effective HIV prevention, treatment not reaching those who could most benefit

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in Children

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in ...

All children with sustained unresponsiveness ingested concentrated and baked egg

Prenatal Vitamin Intake in Early Pregnancy May Cut Autism Risk

Prenatal Vitamin Intake in Early Pregnancy May Cut ...

ASD risk down for children whose mothers took prenatal vitamins during first month of pregnancy

is free, fast, and customized just for you!




Already a member?

Sign In Now »